DDR1 inhibition as a new therapeutic strategy for colorectal cancer

Autor: Audrey Sirvent, Marie Lafitte, Serge Roche
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Zdroj: Molecular & Cellular Oncology, Vol 5, Iss 4 (2018)
Druh dokumentu: article
ISSN: 2372-3556
23723556
DOI: 10.1080/23723556.2018.1465882
Popis: The clinical management of metastatic colorectal cancer (mCRC) is still a major challenge. Recently, we discovered that nilotinib, an approved treatment for chronic myeloid leukaemia, inhibits invasive and metastatic properties of CRC cells by targeting the kinase activity of receptor for collagens DDR1 (Discoïdin Domain Receptor tyrosine kinase 1), suggesting that nilotinib could be an effective strategy to treat mCRC.
Databáze: Directory of Open Access Journals
Nepřihlášeným uživatelům se plný text nezobrazuje